Results 131 to 140 of about 16,696 (258)

Propofol: A Medication That Changed Pediatric Anesthesia Practice

Pediatric Anesthesia, EarlyView.
ABSTRACT The introduction of propofol changed our understanding of pediatric anesthesia pharmacology, research approaches for intravenous drug study, and led to infusion pump development for the maintenance phase of anesthesia. The story of propofol development provides a blueprint for other intravenous drug development.
Brian J. Anderson, L. Ignacio Cortinez
wiley   +1 more source

Flexible organic frameworks sequester neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo. [PDF]

Chem Sci, 2022
Wu Y, Liu YY, Liu HK, Yu SB, Lin F, Zhou W, Wang H, Zhang DW, Li ZT, Ma D.   +9 more
europepmc   +1 more source

Evaluation of Presynaptic Action of Depolarizing Neuromuscular Blocking Agents with Single Twitch Response in Vitro [PDF]

, 2001
Kyung Ho Hwang, Won Seok Chai, Kyu Sik Kang, Yong Ik Kim, Wook Park, Sung Yell Kim   +5 more
openalex   +1 more source

Vision outcomes in dogs with primary glaucoma surgically treated with lensectomy and endolaser cyclophotocoagulation after an Ahmed valve gonioimplantation failure

Veterinary Ophthalmology, Volume 28, Issue 2, Page 207-217, March 2025.
Abstract Objective The aim of this study was to retrospectively evaluate vision outcomes of dogs with primary angle closure glaucoma (PACG) that underwent Ahmed valve gonioimplantation (AVG) followed by lensectomy and endolaser cyclophotocoagulation (ECP) with or without bleb resection after AVG failure.
Bactelius Turicea, Christian L. Munevar, Sydney G. Edwards, Lana L. Linton   +3 more
wiley   +1 more source

Provider variability in the intraoperative use of neuromuscular blocking agents: a retrospective multicentre cohort study. [PDF]

BMJ Open, 2021
Althoff FC, Xu X, Wachtendorf LJ, Shay D, Patrocinio M, Schaefer MS, Houle TT, Fassbender P, Eikermann M, Wongtangman K.   +9 more
europepmc   +1 more source

Transient Cross-Resistance to Neuromuscular Blocking Agents in a Patient with Tetanus [PDF]

, 2003
Jan‐Wei Chiu, Chi-Hsiang Tsou, Jiin-Tarng Liou, Shi-Tai Hsin, Hsiang‐Ning Luk   +4 more
openalex   +1 more source

Blue plaque review series: Dr. Florence Buchanan: A trailblazing physiologist in an era of barriers and breakthroughs

Experimental Physiology, EarlyView.
Abstract What do Charles Darwin, T.H. Huxley, August Krogh and Charles Sherrington have in common? Florence Buchanan – a name history has unjustly dimmed but never erased. Her academic lineage is a direct thread through the titans of biology: E. Ray Lankester mentored her after being shaped by Huxley, Darwin's celebrated protégé.
Brian C. Clark
wiley   +1 more source

IN VITRO STUDY OF INTERACTIONS BETWEEN I.V. ANAESTHETICS AND NEUROMUSCULAR BLOCKING AGENTS

, 1977
P. KRAUNAK, Barbara J Pleuvry, J M H Rees   +2 more
openalex   +1 more source

Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block [PDF]

, 2005
Marissa Shields, M. Giovannelli, R. K. Mirakhur, Iain Moppett, Jonathan Adams, Yvonne Hermens   +5 more
openalex   +1 more source

Effects of acute selective cyclooxygenase‐2 inhibition on skeletal muscle microvascular oxygenation and exercise tolerance

Experimental Physiology, EarlyView.
Abstract The cyclooxygenase (COX) pathway regulates vascular tone and, therefore, local O2 delivery‐utilization matching. The two main isoforms, COX‐1 and COX‐2, may promote opposing effects on contracting muscle O2 transport in health by inducing vasoconstriction and vasodilatation, respectively.
Michael D. Belbis, Michael J. Holmes, Joseph Yao, Christopher W. Kinnick, Christopher K. Kargl, Carly Day, Nicole L. Noel, Timothy P. Gavin, Bruno T. Roseguini, Daniel M. Hirai   +9 more
wiley   +1 more source